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Colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States 
for both men and women combined. CRC screening is an effective way to reduce 
mortality and morbidity related to the disease. Practitioners within primary care practices 
can play an essential role in encouraging people to be screened. Yet, CRC screening rates 
remain low in primary care practices. Evidence-based strategies are available to help 
practitioners improve CRC screening activities and improve screening rates. The lack of 
a clinical practice guideline (CPG) with strategies to help improve CRC screening 
interventions was identified as a practice gap for this project. The practice-focused 
question for this project aimed to address this gap: In a primary care practice, in which 
CRC screening rates are low amongst adults 50 to 75 years of age, evidence-based best 
practices contributed to a CPG for CRC screening in the primary care setting. The 
practice-, provider-, and patient-level (P3) model was utilized to guide the project. 
Evidence from literature and appraisals from a panel of physician and nurse stakeholders 
using the Appraisal of Guidelines for Research & Evaluation (AGREE) II tool was used 
to develop and appraise a CPG and practice workflow. The quality of the proposed CPG 
was validated using the AGREE II tool and receiving a 97.9% overall score and 
consensus from experts that it should be utilized in practice to guide CRC screening 
interventions. The CPG can be disseminated across health systems to help other practices 
implement evidence-based CRC screening guidelines that will enhance screening rates 
resulting in positive social change for patients and communities and improved public 
health. This can support Walden University's mission of positive social change.   
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Section 1: Nature of the Project 
Introduction 
Colorectal cancer (CRC) is used to describe colon cancer, rectum cancer, or both 
(Center for Disease Control and Prevention [CDC], 2019). It is a major population health 
problem contributing to cancer incidence and cancer-related mortality in the United 
States. CRC is the second leading cause of cancer deaths in the United States for men and 
women combined (American Cancer Society [ACS], 2020a). In 2020, the ACS estimated 
147,950 new cases of CRC in the United States and 53,200 deaths. There are several 
options for prevention and early detection. It is well documented that an increase in CRC 
screening rates has reduced mortality and morbidity; however, screening rates are still 
low (Meester et al., 2015).  
The clinical practice problem that was addressed in this project is the low CRC 
screening rates in primary care settings. According to Healthy People 2030 (HP2030), 
CRC screening beginning at age 50 years is the most effective way to reduce a person's 
risk of developing the disease (Office of Disease Prevention and Health Promotion 
[ODPHP], n.d.). In addition, screening allows for early detection when treatment and 
recovery are most effective. CRC typically appears in precancerous polyps, and therefore 
endoscopic removal during a screening colonoscopy reduces the incidence of CRC 
(Triantafillidis et al., 2017). Despite the potentially life-saving effectiveness of CRC 
screening, only 25% of adults 50 to 64 years of age in the United States, and fewer than 
40% of adults age 65 years and older in the United States are up to date on CRC 
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screening (ODPHP, n.d.). The nurse practitioner and other primary care providers (PCPs) 
can play an essential role in encouraging people to be screened.  
According to Paskett and Khuri (2015), several studies have shown that the 
number one reason patients receive CRC screening is because their PCP recommended 
the screening. Most insurances cover the cost of these services; however, CRC screening 
rates remain low in primary care practices. CRC has claimed the lives of many and is 
estimated to claim the lives of many more. Evidence supports that screening significantly 
reduces both mortality and morbidity (Joseph et al., 2016). This DNP project addressed 
this gap by developing a CPG to assist practices with consistently implementing 
evidence-based strategies to improve the process for CRC screening and follow-up from 
PCP settings. The development and utilization of an evidence-based CPG can improve 
the uptake of CRC screenings, align with the national strategy for preventing CRC, and 
reduce the impact on public health. The CPG can be shared across the health system to 
assist other practices in achieving an increased utilization of preventive CRC screenings 
and demonstrate a positive social change for patients, families, and communities, yielding 
a positive public health impact. 
Problem Statement 
The practice problem that was addressed in this project was the low CRC 
screening rates in the primary care setting. The primary care practice setting for 
implementing this Doctor of Nursing Practice (DNP) project was a low-income, inner-
city community in the Mid-Atlantic region. The practice is affected by a high incidence 
of chronic illnesses and multiple social barriers. The practice has consistently struggled 
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with low CRC screening rates of 18-23% - a rate well below the national rate of 67.3% as 
well as the local state rate of 69.5% (CDC, 2017). Despite ongoing efforts in the practice 
to improve CRC screening rates, those screening rates remain significantly low. 
Consequently, practice quality performance targets for preventive screenings are not 
being met. Patients that are due for CRC screening are identified during morning huddles 
and communicated to nursing staff and providers. But frequently, the screening remains 
not completed.  
Low CRC screening rates are especially relevant to address in this population due 
to the disparities that already exist and the circumstances that increase their risk of 
disease and death. Black communities and those of lower socioeconomic status are 
confronted with complexities that increase the risk of CRC-related mortality and 
morbidity. African Americans are about 20% more likely to get CRC and 40% more 
likely to die from it than other racial/ethnic groups (ACS, 2020b). They often face major 
socioeconomic barriers such as lower-paying employment, limited access to nutritious 
and affordable food, poor education and living conditions, and unsafe environments that 
prevent CRC prevention, detection, treatment, and survival. The U.S. Preventive Services 
Task Force (USPSTF, 2016) emphasizes the importance of CRC screenings and 
highlights the evidence that CRC screening substantially reduces deaths from the disease 
among all adults aged 50 to 75 years. According to the USPSTF (2021), there has been an 
increased incidence of CRC in adults younger than 50 years. In addition, African 
Americans have a higher incidence of CRC. However, the most recent update by the 
USPSTF (2021) continues to recommend CRC screening in adults aged 50 to 75 years, 
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and now recommends offering screening starting at 45 years for all adults. There is no 
specific recommendation based on race. Achieving the public health goal of 80% 
screening adherence in age-eligible populations could avert more than 200,000 new 
cancer cases and deaths in the next 20 years (Murphy et al., 2017). Thus, importance is 
placed on enhancing CRC screening rates in primary care settings to significantly attain 
Healthy People 2030 (HP2030) national goals for CRC (USPSTF, 2016).  
In a practice with low CRC screening rates, having a well-defined practice 
workflow and a CPG for nursing staff and providers to follow may help improve CRC 
screening rates. The development, implementation, and consistent use of a CPG for CRC 
screening will ultimately promote early detection of CRC and improve practice and 
patient outcomes. The CPG translates evidence into practice to promote CRC screening 
interventions that can effectively increase screening rates at this practice site and close 
the existing gap in practice. This DNP project holds significance for nursing practice by 
providing guidance, education, and translation of knowledge into nursing practice to 
improve patient outcomes and promote a positive public health change.  
Purpose Statement 
The purpose of this doctoral project was to address the gap in practice related to 
the lack of a standardized process for CRC screening interventions by developing an 
evidence-based CPG. The CPG was developed to provide nursing staff and providers 
with a well-defined protocol that promotes the consistent use of evidence-based strategies 
to improve CRC screening rates in the primary care setting. The guiding practice-focused 
question was: In a primary care practice, in which CRC screening rates are low amongst 
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adults 50 to 75 years of age, what best practices contribute to a CPG for CRC screening 
in the primary care setting? This project provides a standardized protocol to assist the 
staff in ensuring effective strategies are followed consistently to improve CRC screening 
interventions in primary care. 
Nature of the Doctoral Project 
For this project, I obtained evidence by reviewing literature from a multi-database 
search using the Walden University Library, including CINAHL Plus, Medline, SAGE, 
Thoreau, ProQuest, and Google Scholar. Evidence was also collected from publications 
and manuals developed by government and professional organizations to address the 
national strategy of increasing CRC screening rates and reducing the impact of CRC. 
These included the CDC's Colorectal Cancer Control Program (CRCCP), which uses 
strategies recommended by the Guide to Community Preventive Services (CDC, 2020). It 
also included the ACS's National Colorectal Cancer Roundtable's (NCCRT) manual: 
Steps for Increasing Colorectal Cancer Screening Rates: A Manual For Community 
Health Centers (NCCRT, 2020). Additionally, information was utilized from the Walden 
University's Manual for Clinical Practice Guideline Development and the Appraisal of 
Guidelines for Research & Evaluation II (AGREE II) as a framework to develop and 
appraise the quality of a CPG. The use of the practice guideline will improve health care 
delivery and implementation of nursing interventions that improve CRC screening rates 




The primary stakeholders for this DNP project were the practice staff, including 
nurses, medical assistants (MAs), care coordinators, providers, and the patients. The 
provider, the practice, and the patient are all impacted by CRC and the low uptake of 
screening recommendations. CRC is still a significant public health concern and is a 
cause of considerable suffering among more than 140,000 adults diagnosed with CRC 
each year (Simon, 2015). CRC screening reduces the mortality and morbidity of CRC. In 
addition to saving lives and reducing the suffering of patients and families, an increase in 
CRC screening will decrease the economic burden to the Medicare program, insurances, 
and its beneficiaries in the United States. (Yabroff et al., 2018).  
The contributions of this DNP project to nursing practice include enhanced 
knowledge and awareness about CRC and translation of evidence into a practice 
guideline with a step-by-step workflow that will assist nursing staff and providers with 
improving CRC screening interventions and ultimately screening rates in the practice. 
The CPG can be utilized in other primary care practices to assist with their CRC 
screening strategies and improve patient outcomes. This DNP project has the potential to 
create positive social change by providing a framework to increase the early detection 
and prevention of CRC and potentially reaching the public health goal of 80% screening 
adherence in age-eligible adults.  
Summary 
CRC continues to cause significant pain, suffering, and dying in the United States. 
Despite the life-saving effectiveness of CRC screening, the screening rates remain low. 
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Increased screening is well documented as an effective strategy to reduce mortality and 
morbidity, and primary care practices can play an essential role in encouraging people to 
be screened. In Section 1, the student provided a brief introduction of the DNP project, 
including the gap in practice, the problem, the nature of the project, the stakeholders, and 
significance to nursing practice and positive social change. Section 2 introduces the 
model that informed the project, the background and evidence that justifies the 
significance of the project, and the role of the DNP student.  
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Section 2: Background and Context 
Introduction 
The primary care practice of focus for this DNP project has low CRC screening 
rates. Despite efforts to improve the uptake of CRC screening recommendations, rates 
remain low. There was no standard protocol or guideline for the practice nursing staff and 
providers to follow. According to the review of literature, primary care plays a significant 
role in CRC screening programs. CRC screening rates improve when practices have 
effective systems in place with clearly articulated CPGs and PCP involvement 
(Triantafillidis et al., 2017).  
The practice problem addressed in this DNP project was the low CRC screening 
rates in the primary care setting. The practice-focused question aimed at addressing this 
practice gap was: In a primary care practice, in which CRC screening rates are low 
amongst adults 50 to 75 years of age, what best practices contribute to a CPG for CRC 
screening in the primary care setting? The purpose of this DNP project was to address the 
gap in practice related to the lack of a standardized process for CRC screening 
interventions by developing an evidence-based CPG. This CPG sought to provide nursing 
staff and providers with a well-defined protocol that promotes the consistent use of 
evidence-based strategies to improve CRC screening activities in the primary care setting. 
This section elaborates on the guiding models and theories of the project, the relevance to 




Concepts, Models, and Theories 
Preventive interventions such as CRC screening are often suboptimal in the 
primary care setting. Adequate provision of these preventive services may require an 
interaction of activities at all levels of the clinical encounter. The practice-, provider-, and 
patient-level (P3) model provided a framework that was used to guide the development of 
the CPG for this DNP project. It is a framework for addressing preventive care 
interventions using a comprehensive approach at all levels of the encounter. The P3 
model was developed to promote preventive health behaviors and was applied in both 
vaccination and CRC screening programs as examples (Bednarczyk et al., 2018). Thus, 
making it an appropriate framework to utilize in this project to improve CRC screening 
activities in the primary care setting. According to research, interventions grounded in 
theory result in more effective and long-lasting outcomes than interventions not grounded 
in theory (Mojica et al., 2018). 
Unlike other theoretical frameworks that primarily focus on one level of the 
clinical encounter, such as the patient's beliefs and attitudes, the P3 model for preventive 
care interventions focuses on all three levels of the clinical encounter: the patient, 
provider, and practice (Bednarczyk et al., 2018). Practical interventions are designed for 
each component of the model while considering the impacting factors at each level (e.g., 
organizational, reinforcing, situational, cues to action, preventive activity, predisposing, 
enabling, and communication). Planning a program that addresses clinical preventive 
services must consider multiple factors in various levels of medical care, such as 
adequate transportation and time off for workers to help them get the care they need. 
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Addressing these additional factors can reduce barriers to preventive care and improve a 
population's health.  
The P3 model can be used across various settings. The model is a combination of 
key components from several other theoretical models, including the health belief model, 
theory of planned behavior/theory of reasoned action, social cognitive theory, social-
ecological model, and the systems model of clinical preventive care (Bednarczyk et al., 
2018). The P3 model can assist with planning preventive interventions by addressing 
factors that influence each encounter level. This DNP project considered the following 
influencing factors at each encounter level: (a) patient - lack of knowledge, 
nonadherence, and social determinants that prevent screenings; (b) provider - lack of 
time, competing elements, and disagreement with guidelines; and (c) practice - lack of 
effective workflows or evidence-based protocols. According to Bednarczyk et al. (2018), 
the P3 model is adaptable and flexible for use in all types of preventive care promotion 
because of its realistic approach in terms of understanding, developing, implementing, 





Graphical Representation of the P3 (Practice, Provider, Patient) Model  
 
Note. The P3 model shown above with impacting factors and the levels they act on. 
Reprinted from “Practice-, provider-, and patient-level interventions to improve 
preventive care: Development of the P3 Model,” by R. A. Bednarczyk, 2018, Preventive 
Medicine Reports, 11, p. 131-138 (https://doi.org/10.1016/j.pmedr.2018.06.009). 
Copyright 2018 by The Authors. Reprinted with permission. View Appendix A. 
Relevance to Nursing Practice 
A CPG that guides CRC screening activities in a primary care setting advances 
the field of nursing practice by providing a framework for nursing staff and providers to 
improve CRC screening rates within the practice setting. It addresses a gap in clinical 
practice using current evidence. The evidence presented revealed that screening is 
effective in early detection and diagnosis of CRC when medical intervention is most 
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successful in reducing mortality and morbidity related to CRC. However, 40% of the 
U.S. age-eligible patients are still not screened, especially in underserved populations 
(Bresailier et al., 2020). The significant role PCPs play in patient adherence to CRC 
screening guidelines is supported in the literature; however, PCPs are not adequately 
following CRC screening guidelines for several reasons. Many PCPs cite uncertainty 
about screening options, work overload, low patient compliance, and lack of a systematic, 
organized approach as barriers to effective CRC screening activities (Unger-Saldana et 
al., 2020). The lack of a standardized, evidence-based guideline within the primary care 
setting for this DNP project may have contributed to low CRC screening rates amongst 
patients and ultimately the burden of CRC in the community.  
Nurses maintain accountability for their patients by ensuring that high-quality and 
efficient care is provided to all patients. Nursing staff and providers contribute to clinical 
practice outcomes by translating EBP into clinical interventions that promote health and 
disease prevention. By assisting with the development of a standardized protocol for the 
CRC screening pathway in the primary care practice, nursing staff and providers are more 
engaged with a guided process for screening activities to improve overall CRC screening 
rates. A team-based approach with defined roles is most effective at supporting the 
activities and ensuring compliance with the protocol. The CPG increases awareness and 
understanding of the problem amongst nursing staff and providers, increasing their 
confidence in carrying out the screening activities. The IOM (2011) informed that CPGs 
provide a framework for establishing best practices backed by evidence to improve 
patient care and outcomes. They provide a systematic approach that brings together 
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policy, best practices, and patient choice for improved outcomes. The CPG that was 
developed for this DNP project incorporates evidence and theory from the literature 
review and formulates a well-defined protocol with best practice guidelines to improve 
CRC screening activities in the primary care practice.  
The following sections summarize the evidence obtained from the literature 
review that support the interventions outlined in the CPG. These sections include 
evidence regarding the importance of CRC screening, screening recommendations, and 
evidence-based practices that contribute to higher CRC screening rates in primary care 
practice settings including: (a) PCP engagement, (b) use of a team-based model, (c) 
patient education and decision making, and (d) utilizing a multicomponent approach to 
improve screening compliance. 
CRC  
CRC refers to cancer that starts in the colon (also known as the large intestine) or 
rectum. It is one of the deadliest cancers in the United States. According to ACS (2020c), 
CRC is the second leading cause of cancer-related deaths in the United States for both 
men and women combined. Nearly 135,000 people in the United States are diagnosed 
with CRC each year, and over 50,000 die because of it annually. According to most 
recent data from the Surveillance, Epidemiology, and End Results (SEER, 2018), CRC 
represents 8.1% of all new cancer cases in the United States. The data estimates 
1,332,085 people living with CRC in the United States with 39.4 new cases per 100,000 
men and women per year and 14.5 deaths per 100,000 men and women per year. It is 
estimated that 4.4% of men (1 in 23) and 4.1% of women (1 in 25) will be diagnosed with 
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CRC in their lifetime. At 5 years after diagnosis, the relative survival rate for CRC is 
64%, and at 10 years, it is 58% (ACS, 2020c). Additionally, this will have a substantial 
future economic burden on the Medicare program and its beneficiaries in the United 
States. 
CRC usually begins as a noncancerous (benign) adenoma or polyp (abnormal 
growth) on the colon or rectum lining. Because of their proclivity for malignant 
transformation, colon polyps are thought to be a gateway to CRC (Aydin & Aydin, 
2021). Polyps are usually asymptomatic and provide no indication that they are present. 
Some present with major symptoms, including bleeding, abdominal pain, changes in 
bowel habits, and intestinal obstruction. Colon polyps or growths can be removed during 
a screening colonoscopy to significantly reduce the risk of cancer. If left undetected or 
untreated, they can develop into cancer. The risk of a colon polyp developing into cancer 
can range from 8% to 24% in 10 to 20 years, respectively (Aydin & Aydin, 2021). Thus, 
early detection and endoscopic removal of colon polyps are critical to preventing CRC.  
CRC Screening Recommendations 
Compelling research has shown that evidence-based screening is quite effective in 
early identification, prevention, and improved prognosis of treatment of CRC (USPSTF, 
2016). The USPSTF (2016) recommendations are based on a rigorous review of existing 
peer-reviewed evidence. They are intended to help primary care clinicians and patients 
decide together whether a preventive service is right for a patient's needs. The most 
recent update by the USPSTF (2021) continues to recommend CRC screening in adults 
aged 50 to 75 years, and now recommends offering screening starting at 45 years for all 
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adults even if risk factors are absent. CRC screening may include all screening options, 
including stool-based testing with either high-sensitivity quiac-based fecal occult blood 
testing (HSgFOBT) or fecal immunochemical test (FIT), colonoscopy, and 
sigmoidoscopy. The ACS also recommends starting CRC screening at age 45 years 
through age 75 years (Wolf et al., 2018). The decision to screen between age 76 and 85 
years is still based on patient screening history, life expectancy, and health status 
(USPSTF, 2021). Screening is usually stopped at age 85 years. The USPSTF (2021) 
emphasizes that all options are acceptable and that the focus should be on getting the 
screening completed since there is strong evidence that screening reduces the incidence 
and mortality of CRC. According to the NCCRT (2020), colonoscopy every 10 years or 
annual stool-based blood testing are the two most common screening methods for 
average-risk patients. Sigmoidoscopy is not frequently used; however, it is an effective 
screening method if used with high-quality techniques, and a positive screening is 
referred for colonoscopy.  
Despite the evidence that screening is an effective intervention to prevent CRC 
and promote early detection when treatment is more successful, a significant portion of 
age-appropriate adults are still not being screened. Therefore, the best option is the one 
that is mostly likely to be utilized, and there is no overwhelming evidence that one is 
more effective than the other (Shellnutt, 2020). Thus, when developing a CRC screening 
program, it is best to consider the population's barriers to screening and their preferences. 
For example, disadvantaged populations with barriers related to access, and 
socioeconomic status, may prefer using HSgFOBT or FIT as a less invasive evidence-
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based screening method. Further, the NCCRT (2020) emphasizes using both colonoscopy 
and stool-based tests to reach target CRC screening rates. 
Evidence-Based Practices for CRC Screening 
Provider Engagement 
Researchers have supported achieving the public health goal of 80% screening 
adherence in age-appropriate populations to avert more than 200,000 new cancer cases 
and deaths in the next 20 years (Murphy et al., 2017). The role of primary care is critical 
to improving CRC screening rates and achieving the national targets. According to 
Triantafillidis et al. (2017), CRC screening requires the input of the PCP. The PCP can 
impact the CRC screening path, starting with the patient reminder, screening enrollment, 
referral, early diagnosis, and pre-and post-treatment care for cancer. The PCP and nursing 
staff are typically the initial point of contact with the patient in the CRC screening 
pathway, collaborating with specialists and offering screening options. The PCP 
recommendations and endorsement is a critical determinant in screening participation. 
The success indicator of CRC screening activities is in the amount of PCP involvement 
and the ability to integrate effective screening systems and procedures in service delivery 
(Triantafillidis et al., 2017). PCPs are in a position to ensure high-quality care for their 
patients. Further, having a well-defined CPG with clinical workflows that support a 
comprehensive approach to CRC screening and evidence-based primary care 




Patient and provider communication is critical in selecting the screening modality 
that will get done. Updated ACS guidelines for CRC screening highlights the importance 
of the patient's choice when selecting a screening test (Volk et al., 2018). The goal is to 
increase compliance and adherence to CRC screenings. Further, researchers have shown 
that patients are more adherent to CRC screening when presented with options that meet 
their preferences. The decision-making should be collaborative. Numerous researchers 
have shown that the number one reason patients are adherent to CRC screening is that 
their PCP recommended the test (Triantafillidis et al., 2017). In one study, patients were 
less adherent to screening when colonoscopy alone was recommended than to when 
stool-based screening alone or a choice of both options. If possible, practices should 
facilitate both screening colonoscopy and high-sensitivity stool testing as options. PCPs 
must educate patients on the importance of CRC screening and recommend screening 
options to all eligible patients and have a systematic way to provide follow-up to ensure 
the recommendation was followed and assist with a referral for cancer treatment as 
needed.  
Practice Team-Based Approach 
As previously stated, providers complained about not having enough time or 
resources to address preventive screening services such as CRC. They also complained of 
work overload. According to Dill et al. (2019), efforts to improve the delivery of care 
within primary care practices increasingly focus on redesigning care in ways that utilize 
the entire primary care team, such as nurse practitioners, physician assistants, nursing 
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staff, care coordinators, and the MAs. Miller (2019) highlighted several studies in which 
the MA role was expanded to assist PCPs with improving preventive screening services 
and demonstrated an increase in patients up-to-date with CRC screening from 23% to 
34%. Another study showed the expanded MA role was associated with a 123% 
improvement in colonoscopy referrals among seven practices in Utah (Miller, 2019). 
Researchers have demonstrated an overall improvement in primary care workforce 
efficiency and quality when a team-based approach is implemented (Jerzak, 2019). 
Multiple studies demonstrate the vital role of primary care in adherence to CRC 
screening strategies. However, the PCP cannot do it alone. A systematic approach 
requires the involvement of the PCP and the practice staff to support the role of primary 
care in achieving quality outcomes and implementing effective CRC screening strategies 
(Holden et al., 2020). In addition, health information technology (HIT) can support the 
practice and system-level interventions (e.g., health maintenance records that identify 
patients due for screenings and automated provider reminders), which are known to be 
effective screening strategies (Jerzak, 2019). Bringing awareness about the importance of 
CRC screening to the team and defining their roles to implement multiple evidence-based 
interventions has shown to be an effective approach at improving CRC screening rates in 
primary care practice (Triantafillidis, 2017). 
Multicomponent Approach 
According to the Community Preventive Services Task Force (CPSTF, 2017), 
strong evidence indicates the use of multicomponent interventions to effectively increase 
CRC screening. The CSPTF developed a Guide to Community Preventive Services with 
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a list of evidence-based interventions for increasing CRC screening. The interventions are 
divided into three strategies: increasing community demand, increasing community 
access, and increasing provider delivery. A multicomponent approach combines two or 
more of these strategies. A systematic review of studies by the CPSTF (2017) revealed 
that colonoscopy and stool based (FOBT) screening improved by 15.4 % as a result of 
multicomponent interventions. The most significant increases were yielded when 
interventions were combined from all three strategies (CPSTF, 2017). Other studies that 
were reviewed to support this DNP project also emphasized the importance of multilevel 
interventions over single-level interventions to lead sustainable changes.  
Recommended interventions target all three levels of the clinical encounter: the 
provider, the practice, and the patient (Kim et al., 2020). Four of the evidence-based 
interventions listed in the Guide to Community Preventive Services have been prioritized 
by the CDC as most helpful in increasing CRC screening rates, including: (a) patient 
reminders – reminder messages to patients that they are due for screening using various 
methods (e.g., text, letter, email or phone); (b) provider reminders – a reminder to 
providers that a patient is due or overdue for screening; (c) provider assessment and 
feedback – monitor and track provider and practice performance on CRC screening rates 
and inform provider/practice of performance; and (d) reducing structural barriers – 
interventions that reduce noneconomic barriers and facilitate access to screening. Patient 
navigation (guiding patients through health care barriers and helping them access 
screening and follow-up) and small media (videos and printed materials) are other 
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effective interventions that can be added to improve screening rates (DeGross et al., 
2018).  
Several evidence-based strategies work to help improve CRC screenings in the 
community. According to the literature review, they worked best when more than one 
intervention was utilized together. Federally qualified health centers or practices in 
underserved areas have low CRC screening rates. This DNP project advances nursing 
practice by providing a systematic guideline with a practice protocol that includes 
multicomponent interventions to assist the nursing staff and providers in CRC strategies 
that increase the screening rates within the primary care practice.  
Local Background and Context 
The evidence identified at the practice site that supports the relevance of the 
problem involves the below-average screening rates and provider and nursing staff's view 
of not having resources or a systematic protocol to help guide screening activities. The 
physicians, nurse practitioners, and other nursing staff explained that there was no 
standard guideline for assisting staff with screening activities that will help improve the 
CRC screening process. Although referrals were being made for colonoscopy and FIT 
testing, screening recommendations varied by provider, and patients were not completing 
the screenings. Further, nursing staff and providers were not aware of their individual 
performance or the practice performance for CRC screening compared to local or 
national benchmarks.  
The practice site for this DNP project was a primary care practice located in a 
low-income, inner-city neighborhood in the Mid-Atlantic area. The practice is a part of a 
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free-standing medical facility that houses an emergency room, observation unit, 
outpatient substance abuse, behavior clinics, and diagnostic testing. The facility is part of 
a large local health system. The practice is impacted by a high incidence of chronic 
illnesses and multiple social barriers related to income, education level, housing, and 
substance use. Despite ongoing efforts to improve preventive screening rates, the practice 
has long struggled with low CRC screening rates of 18-23% – a rate well below the local 
state rate of 69.5 % and the national rate of 67.3 % (CDC, 2017).  
Achieving the public health goal of 80% screening adherence in age-eligible 
populations could avert thousands of new cancer cases and deaths each year. (Murphy et 
al., 2017). Thus, importance is placed on strategies that enhance CRC screening rates in 
the primary care settings (USPSTF, 2016). A CPG could enhance provider and nursing 
staff awareness of the problem and help guide evidence-based practices to increase their 
confidence and ability to improve CRC screening rates. 
Role of the DNP Student 
As an advanced practice nurse practitioner, nurse leader, and DNP student, I have 
been involved with multiple quality improvement initiatives to help improve patient care, 
patient outcomes, and operational practices. I have been working for the practice site as 
the director for population health and ambulatory practices over the past 8 years. I have 
had the responsibility of tracking quality measures, addressing gaps with providers and 
practices, and implementing programs to improve metrics and outcomes. CRC screening 
rates were identified as one of the practice metrics in which a significant opportunity to 
improve was noted. Three years ago, the practice participated in a 3-month pilot with the 
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local health department to educate providers and patients on CRC and received $1,000.00 
to assist with educational materials, incentives ($10 gift cards to return FIT test), and 
transportation needs. The project yielded a 10% increase in CRC screening rates. 
However, once the incentives were gone, rates soon dropped back to baseline, which was 
well below the local average.  
Personally, the motivation for this DNP project came from a pursuit to understand 
why CRC screening rates were so low in this population, knowing that CRC screening 
could save many lives. I realized that nursing staff and providers had nothing in place to 
guide their workflow. I wanted to identify and remove the barriers for the nursing staff 
and the patients to improve compliance rates with CRC screening, an effective preventive 
service. I also had two close relatives diagnosed and treated for CRC; one is a 70 year old 
who is now a 10 year survivor, and the other was a 46 year old who succumbed to CRC 
this year after a 3-year battle. My role in this DNP project was to translate evidence-
based strategies into a CPG to assist the nursing staff and providers in CRC screening 
interventions. A CPG would significantly improve CRC screening rates at the practice 
site and could be used by other practices to improve patient outcomes. My motivations 
made me aware of potential biases I may have had. Therefore I identified a project team 
to evaluate the evidence and the CPG utilizing the AGREE II tool.  
Role of the Project Team 
The project team consisted of the Chief Medical Officer (CMO), two family 
practice providers, including one family nurse practitioner and one physician, the practice 
manager, the nurse manager, the director of quality who is a registered nurse, and the 
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DNP student. The project team was presented with information about the practice 
problem and performance, local and national targets, evidence to support the DNP project 
and CPG, and the utilization of the AGREE II evaluation tool. The team helped revise the 
CPG based on their recommendations and provided final approval prior to submission to 
the medical executive board (MEC). The final CPG was disseminated to all key 
stakeholders, including the practice manager of the primary care practice for practice 
implementation.  
Summary 
In this section, the student presented the P3 model that was used as a framework 
to guide this DNP project and the development of a CPG for CRC screening in the 
primary care practice. The student discussed evidence with the team that supported the 
screening recommendations and strategies that were incorporated in the CPG to improve 
CRC screening activities. The student discussed the gap in practice and significance to 
nursing practice, the local background, the role as the DNP student, and the role of the 
project team in the development of the CPG using the AGREE II evaluation tool. Section 
three describes the project’s data collection, analysis, synthesis, and summary. 
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Section 3: Collection and Analysis of Evidence 
Introduction 
CRC is the second leading cause of cancer deaths in the United States for men 
and women combined, claiming over 50,000 lives annually (ACS, 2020). There are 
several options for prevention and early detection. It is well documented that an increase 
in CRC screening can reduce mortality and morbidity; however, screening rates are still 
low (Meester et al., 2015). Despite the potentially life-saving effectiveness of CRC 
screening, only 25% of adults aged 50 to 64 years in the United States, and fewer than 
40% of adults aged 65 years and older in the United States are up to date on CRC 
screening (ODPHP, n.d.). The clinical practice problem that was addressed in this project 
is the low CRC screening rates in primary care settings.  
The primary care practice setting for the implementation of this DNP project has 
consistently struggled with low CRC screening rates of 18% to 23% - a rate well below 
the national rate of 67.3% as well as the local state rate of 69.5% (CDC, 2017). Despite 
ongoing efforts in the practice to improve CRC screening rates, those screening rates 
remain significantly low. During a department staff meeting, providers and nursing staff 
explained that there is no standard protocol or resources to assist with CRC screening 
activities. They verbalized frustration related to the patient's referral and appointment 
noncompliance. The practice is located in a disadvantaged community in which patients 
are impacted by multiple social barriers that contribute to their healthcare practices. The 
purpose of this doctoral project was to address the gap in practice related to the lack of a 
standardized process for CRC screening interventions by developing a CPG. The CPG 
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provides the nursing staff and providers with a well-defined protocol that promotes the 
consistent use of evidence-based strategies to improve CRC screening activities in the 
primary care setting.  
Practice-Focused Question(s) 
The primary care practice for this DNP project has consistently struggled with 
low CRC screening rates of 18% to 23% - a rate well below the national rate of 67.3% as 
well as the local state rate of 69.5% (CDC, 2017). Efforts to improve CRC screening 
rates have not been successful, and screening rates remain significantly low. 
Consequently, practice quality metric targets for preventive screenings are not being met. 
Patients that are due for CRC screening are identified during morning huddles and 
communicated to nursing staff and providers. But frequently, the screening remains not 
completed. The purpose of this doctoral project was to address the gap in practice related 
to the lack of a standardized process for CRC screening interventions by developing a 
CPG. The CPG provided nursing staff and providers with a well-defined protocol that 
promotes the consistent use of evidence-based strategies for CRC screening interventions 
in the primary care setting. The practice-focused question aimed at addressing this 
practice gap was: In a primary care practice, in which CRC screening rates are low 
amongst adults 50 to 75 years of age, what best practices contribute to a CPG for CRC 
screening in the primary care setting? This project provides a standardized CPG with a 
protocol to assist the staff in ensuring effective strategies are followed consistently to 
improve CRC screening activities in primary care.  
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Sources of Evidence 
To address the practice-focused question, the student reviewed, organized, and 
appraised literature containing evidence on best practices for CRC screening to be 
utilized in a primary care practice. The review of literature was obtained from a multi-
database search using the Walden University Library, including CINAHL Plus, Medline, 
SAGE, Thoreau, ProQuest, and Google Scholar. The scope of the evidence was within 
the last five years from peer-reviewed journals, articles, and books. Evidence was also 
collected from publications and manuals developed by government and professional 
organizations to address the national strategy of increasing CRC screening rates and 
reducing the impact of CRC. These included the USPSTF because they provided 
information based on a rigorous review of existing peer-reviewed evidence and are 
intended to help practices make decisions regarding preventive services such as CRC 
screening. In addition, the CDC’s Colorectal Cancer Control Program (CRCCP), which 
used strategies recommended by the Guide to Community Preventive Services (CDC, 
2020). Also included was the ACS's Steps for Increasing Colorectal Cancer Screening 
Rates: A Manual for Community Health Centers (NCCRT, 2020) because they were most 
appropriate to the target population.  
The following search terms were used in the literature search: colon cancer, 
colorectal cancer, colorectal cancer screening, colorectal cancer screening and primary 
care, preventive care, clinical practice guidelines, teamwork, CRC screening strategies, 
medical assistants, and team-based care. Inclusion criteria included articles written in 
English, peer-reviewed sources, and published within the past 5 years. Exclusion criteria 
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included literature related to cancer diagnosis and treatment. In addition, guidelines from 
the Walden University's Manual for Clinical Practice Guideline Development were 
followed along with feedback from an expert panel to develop the CPG.  
Tools from the Centre for Evidence Based Medicine (CEBM, 2011), and the 
Johns Hopkins Medicine Center for Evidence-Based Practice (n.d.) were used to review, 
appraise, and categorize the literature by topic, strategy and quality using the following 
criteria: (a) author and date, (b) design, (c) topic, (d) strategy, (e) findings, (f) 
implications, and (g) level of evidence. The grading and scoring of the evidence in the 
literature review was done according to the Oxford Centre for Evidence Based Medicine 
(OCEBM) Levels of Evidence Table and the Johns Hopkins Nursing Evidence-Based 
Practice (JHNEBP) Level and Quality Guide (see Appendices B and C). The summary of 
the review and appraisal can be found in Appendix E. Notes were maintained on each 
article to keep track of those that were kept for inclusion and stored on a personal 
computer using Citefast, a citation generator tool.  
The purpose of the DNP project was met by conducting a comprehensive 
literature review to support best practices for CRC screening, which were incorporated 
into a CPG to address the gap in practice related to the lack of a standardized process for 
CRC screening. This literature review assisted with identifying valuable and relevant 
evidence that supported the recommendations for the CPG and practice protocol.  
 Additionally, the Walden University’s Manual for Clinical Practice Guideline 
Development, expert opinion, and the AGREE II framework was used to assist with 
developing the CPG. The expert panel consisted of five individuals, the Chief Medical 
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Officer (CMO), a family nurse practitioner, a family medicine physician, the practice 
manager, and the Director of Quality, who is a registered nurse. The DNP student met 
with the expert panel to provide and discuss the literature review and summary of 
evidence that was utilized to develop the CPG. This can be viewed in Appendix E. A 
draft of the CPG was developed using the steps in the AGREE II framework. The expert 
panel was provided instructions on the use of the AGREE II tool in which they used to 
evaluate and comment on the contents of the proposed CPG. This is elaborated on in the 
next section. 
The DNP project did not consist of any experimental risks to human subjects. 
Expert panelist responses to the AGREE II tool was anonymized. The reviewers received 
the CPG with appendices, and the AGREE II tool along with instructions for rating each 
item. They were asked not to write their names on the tool, and to place the completed 
tool in the envelop provide into the DNP students mailbox. The project was submitted to 
the Walden Institutional Review Board (IRB) for approval prior to implementing this 
project. All ethical requirements outlined in the Walden University Manual for Clinical 
Practice Guideline Development was adhered to. The practice guideline that was 
developed was based on evidence from the literature for best practice strategies to 
improve CRC screening activities in the primary care setting. No ethical issues were 
identified as potential problems for the DNP project.  
Analysis and Synthesis 
The DNP project was a CPG development project. Once the CPG was developed, 
the AGREE II tool was used by the expert panel to evaluate the quality of the guideline 
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developed. It is a valid and reliable tool, comprised of 23 key items and six quality 
domains to guide the process (Brouwers et al., 2010; Walden University, 2019). Steps for 
developing the CPG included defining the scope and purpose of the project, getting 
stakeholder involvement, using rigor to develop the guideline, presenting an applicable 
guideline with clarity, and formation of the guideline without bias (Walden University, 
2019). Instructions were provided to the expert panel on the utilization of the AGREE II 
instrument. The expert panel reviewed the CPG using the AGREE II instrument to 
validate content and make recommendations before the final report. The CPG provided 
nursing staff and providers with a well-defined protocol that promotes the consistent use 
of evidence-based strategies for CRC screening activities in the primary care setting. 
The AGREE II tool contains 23 items and two global rating items that the expert 
panel scored using a 7 point scale (1- strongly disagree to 7-strongly agree). A quality 
score was calculated for each domain and given a percentage of the maximum possible 
score for that domain. A quality threshold was set at greater than 70% across all domains. 
The DNP student and expert panel discussed the ratings for each domain and came to a 
consensus to make revisions for those domains scoring less than 70%. Priority was given 
to the overall assessment section, which included 2 items. This section required the 
expert panel to make a judgment as to the quality of the guideline (item 1) and whether 
they would recommend the use of the guideline (item 2). Item 1 of this section was 
required to receive a rating greater than 70% to be considered high quality; and for item 2 
of this section the guideline had to be recommended for use by all reviewers. The student 
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made revisions based on the ratings and comments from the expert panel and resubmitted 
for final review and approval. 
As stated earlier, the guideline was revised based on the student's and the expert 
panel's consensus on recommendations across all domains. All recommendations had to 
align with the evidence. Although none existed, disagreements were to be resolved 
through the use of evidence to support decisions, with the CMO making the final 
determination. The final revisions were resubmitted for approval. The final guideline was 
distributed to all key stakeholders, including the practice manager of the primary care 
practice, for implementation. Prior to implementing the CPG, the practice CRC screening 
rates were noted for future analysis outside the scope of this DNP project. 
Summary 
Section 3 described the sources of evidence used to support this DNP project. Key 
expert sources contributed evidence-based recommendations to address low CRC 
screening rates in the primary care setting. The student discussed the literature search, 
appraisal of evidence, expert feedback, government publications and manuals, and other 
tools that were used to develop and appraise the CPG. The student elaborated on 
procedures, project team, protections, and process of analysis and synthesis to advance 
the project.  
In Section 4, the findings and recommendations from the expert panel and the 
development of the CPG are reviewed. The strengths and limitations of the project are 




Section 4: Findings and Recommendations 
Introduction 
The setting for this DNP project was a family practice located in a low-income, 
inner-city neighborhood in the Mid-Atlantic area. Despite ongoing efforts to improve 
preventive screening rates, the practice had consistently struggled with low CRC 
screening rates well below the national and state rate. The practice lacked a standardized 
protocol in place to assist nursing staff and providers with CRC screening activities. The 
guiding practice-focused question was: In a primary care practice, in which CRC 
screening rates are low amongst adults 50 to 75 years of age, what best practices 
contribute to a CPG for CRC screening in the primary care setting? The purpose of this 
DNP project was to address the gap in practice by developing an evidence-based CPG 
with a well-defined protocol that would promote the consistent use of evidence-based 
strategies to improve CRC activities in the practice setting.  
The sources of evidence used to create the CPG included literature containing 
systematic reviews, peer-reviewed articles, publications and manuals from government 
and professional organizations, and expert recommendations. Literature was obtained 
from a multi-database search using the Walden University Library, including material 
published within 5 years. The student reviewed, organized, and appraised the evidence 
from the literature using tools from the CEBM and the JHNEBP Model. The grading and 
scoring of the evidence in the literature review were done according to the OCEBM 
Levels of Evidence Table and the JHNEBP Level and Quality Guide (see Appendices B 
and C). The summary of the review and appraisal can be found in Appendix E. The 
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evidence was categorized by topic and strategy and appraised for the level of evidence 
and strength of recommendations. Although OCEBM Levels of Evidence Table was 
primarily used to appraise evidence from systematic reviews and individual studies, the 
JHNEBP Level and Quality Guide was used to appraise editorials and peer-reviewed 
articles not accounted for in the OCEBM Levels of Evidence Table. The use of both 
models allowed for a more extensive reach of studies during the appraisal.  
In addition to leveling of evidence, a grade was given for strength ranging from A 
for high quality or consistent level 1 studies, B for good quality or consistent level 2 or 3 
studies or extrapolations from level 1 studies, C for low quality or level 4 studies, and D 
for level 5 or inconsistent studies. Recommendations were formulated based on 
consistent evidence appraised for strength, relevance, and value for developing the CPG 
for CRC screening in the primary care setting. Additionally, an expert panel provided 
feedback and recommendations that also served as a source of evidence used to create the 
CPG.   
Findings and Implications 
An expert panel evaluated the recommended CPG using the AGREE II tool to 
validate the guideline's content. Additional members were added to the expert panel 
while some members were replaced due to conflicting priorities among two members and 
requests from other significant stakeholders to participate. Overall, eight panel members 
reviewed the CPG using the AGREE II tool, thereby increasing the assessment's 
reliability. The reviewers included the practice manager, the newly hired nurse manager, 
three practice providers (a family practice physician, a nurse practitioner, and a physician 
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assistant), the Director of Nursing Education (a DNP-prepared nurse), the Director of 
Case Management (a DNP-prepared nurse), and the CMO. 
Each panel member was provided the proposed CPG, the Agree II Tool, 
instructions on using the tool and was asked to return the completed tool in a sealed 
envelope. As previously stated, the AGREE II tool consists of 23 items that assess six 
domains and two overall assessment questions. The overall assessment section required 
the reviewer to rate the guideline's quality and determine whether they would recommend 
its use. Each item was rated using a 7 point scale (1- strongly disagree to 7-strongly 
agree), and some reviewers added additional comments. After that, a quality score for 
each domain was calculated according to the AGREE Next Steps Consortium's 
instructions (2017). Each domain quality score was calculated by totaling all the scores of 
the individual items within the domain minus the minimum possible score for that 
domain, then divided by the maximum possible score for that domain minus the 
minimum possible score for that domain. This number was then multiplied by 100 for the 
percentage. As previously stated, a quality threshold was set at greater than 70% across 
all domains to be considered high quality. Table 1 contains the reviewer's scores for each 
domain. Based on the scoring, the reviewers gave a high rating of 97.9% for the overall 






AGREE II Expert Panel Results 
Domains Expert 1 Expert 2 Expert 3 Expert 4 Expert 5 Expert 6 Expert 7 Expert 8 Total 
Domain 1          
Item 1 7 7 7 7 7 7 7 7 56 
Item 2 7 7 7 7 7 7 7 7 56 
Item 3  7 7 7 7 7 6 7 7 55 
Domain 2          
Item 4 7 7 7 7 7 6 7 7 55 
Item 5 6 6 7 7 7 4 7 7 51 
Item 6  7 6 7 7 7 7 7 7 55 
Domain 3          
Item 7 7 7 7 7 7 6 7 7 55 
Item 8 5 7 7 7 7 7 7 7 54 
Item 9  7 7 7 5 7 6 7 7 53 
Item 10 7 7 7 7 7 7 7 7 56 
Item 11 7 7 7 7 7 7 7 5 54 
Item 12 7 7 7 7 7 6 7 7 55 
Item 13 7 7 6 7 7 7 7 7 55 
Item 14 1 1 7 7 7 3 7 7 40 
Domain 4          
Item 15 7 7 7 7 7 6 7 7 55 
Item 16 7 7 7 7 7 7 7 7 56 
Item 17 7 7 6 7 7 7 7 7 55 
Domain 5          
Item 18 7 7 7 7 7 6 7 7 55 
Item 19 7 7 7 7 7 7 7 7 56 
Item 20 7 7 7 7 7 6 7 7 55 
Item 21 7 7 7 6 7 6 7 7 54 
Domain 6          
Item 22 7 7 7 6 7 7 7 7 55 
Item 23 1 7 6 7 7 7 7 7 49 
Overall 
Assessment 
         






7 7 7 7 7 6 7 7 55 
          
Item 2 










 Domain 1 of the AGREE II tool considers the guideline's scope and purpose, 
focusing on the overall aim, specific health questions, and target population (AGREE 
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Next Steps Consortium (2017). The domain quality score for domain 1 was 99.3%. There 
were no suggested modifications for this domain. Two reviewers commented that a CPG 
that includes a practice protocol such as the recommended guideline is critical to CRC 
screening in low to average-risk populations. All reviewers commented that the 
guideline's purpose was clear and well stated. 
Domain 2  
 Domain 2 of the AGREE II tool considers stakeholder involvement and focuses 
on whether the guideline development included the appropriate stakeholders and speaks 
to the intended users (AGREE Next Steps Consortium (2017). The domain quality score 
for domain 2 was 95.1%. One reviewer commented that the inclusion of the MA was 
valuable and unique to this practice guideline. Another reviewer asked the DNP student 
scholar to clarify the difference between the target population and the stakeholders. It was 
explained that the stakeholders are the intended users of the CPG in practice targeting 
age-appropriate average risk patients for screening. The score for this domain reflects 
appropriate stakeholder involvement. 
Domain 3 
 Domain 3 of the AGREE II tool considers the rigor of development of the 
guideline (AGREE Next Steps Consortium (2017). This domain focuses on the 
systematic review, synthesis, and analysis of the evidence to formulate the 
recommendations for the guideline. The domain quality score for domain 3 was 93.2%. 
One of the reviewers asked about the exclusion criteria and limitations in the literature. 
The reviewers were directed to view the evidence table provided to them upon this 
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request. This table can be viewed in Appendix E. There was also a question about how 
often the guideline would be updated. It was explained that this would be based on the 
organizational policy. No suggestions for modification were noted. The score and 
comments for this domain reflected the reviewer's consensus that the guideline was well 
developed, the evidence was clear and relevant, and the recommendations were aligned 
with the evidence.  
Domain 4 
 Domain 4 of the AGREE II tool assesses clarity of presentation related to the 
guideline's language, structure, and format (AGREE Next Steps Consortium, 2017). The 
domain quality score for domain 4 was 98.6%. The reviewers commented that the 
guideline was thorough, well-written, and concise. One reviewer stated that the inclusion 
of a practice protocol with staff responsibilities was incredibly beneficial. Another 
reviewer commented that using the P3 Model to develop the guideline and establish 
interventions for each encounter level is highly appropriate and beneficial to the practice. 
The score for this domain reflects the reviewer's agreement with the guideline and 
opinion that the guideline is presented clearly. 
Domain 5  
 Domain 5 of the AGREE II tool examines the guideline's applicability in relation 
to barriers and facilitators for implementation, plus the various strategies to increase 
usage and resources required to incorporate the guideline (AGREE Next Steps 
Consortium, 2017). The domain quality score for domain 5 was 97.9%. One reviewer 
commented that the inclusion of the staff roles and practice protocol was an essential 
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component for implementation and utilization. The score for this domain represents the 
reviewer's consensus that the guideline is relevant and appropriate for implementation in 
the practice.  
Domain 6 
 Domain 6 of the AGREE II tool considers editorial independence, which focuses 
on the guideline's recommendations being free from bias due to competing interests 
(AGREE Next Steps Consortium, 2017). The domain quality score for domain 6 was 
91.7%. There was a comment that this was not recorded or mentioned in the guideline. It 
was pointed out to the reviewers and noted in the CPG that there were no competing 
interests. The score reflects agreement. 
Overall Assessment 
 The overall assessment is the final section of the AGREE II tool and consists of 
two questions. This section requires the reviewer to take into account all the previous 
items and make a judgment related to the overall quality of the guideline and whether the 
guideline should be recommended for use in the practice (AGREE Next Steps 
Consortium (2017). As stated in the AGREE II Next Steps Consortium (2017), it is 
important to point out that there is a degree of personal judgment required when giving 
guideline ratings. To assist the reviewers, the criteria and considerations are there to 
guide rather than to replace it.  
 The reviewer's scores for the first question related to the overall quality of the 
guideline was 97.9%, reflecting agreement amongst the reviewers and a high rating for 
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the overall quality of the CPG. For the second question, which asks would you 
recommend this guideline for use, all reviewers answered Yes.   
 The review and appraisal of this CPG yields recommendations to guide CRC 
screening interventions in the primary care setting. One limitation noted was the lack of a 
procedure for updating the guideline. The student added a notation to the guideline that 
the organization policy would be adhered to for updating guidelines (e.g., annually or 
every 3 years). Another observation was the lack of a process for auditing and monitoring 
staff compliance with roles and responsibilities. Although mentioned in the step-by-step 
protocol as a role for practice management or administration, the process was not 
described in detail. The expert panel suggested random chart reviews as needed but was 
satisfied with the provision of practice and provider performance data on CRC screening 
rates as stated in the protocol. The practice CRC screening rates prior to implementing 
the CPG were noted for future analysis outside the scope of this DNP project. Lastly, the 
student added a comment to the guideline to state that the guideline was free of bias due 
to competing interests. 
 Developing the CPG with a well-defined practice protocol for the primary 
practice will give providers and staff a step-by-step workflow to improve CRC screening 
interventions within the practice. As stated throughout this DNP project, evidence 
supports that increased CRC screening can save many lives. The CPG can enhance the 
uptake of CRC screenings, align with the national strategy for preventing CRC, and 
reduce the impact on public health. This positive change will impact the lives of many 
and improve human and social conditions that support the National Colorectal 
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Roundtable initiative to achieve 80% screening rates in every community (Shellnutt, 
2020). The CPG can be shared across health systems to assist other practices in 
increasing utilization of preventive CRC screenings and demonstrating a positive social 
change for patients, families, communities, and organizations, yielding a positive public 
health impact. This positive public health impact can support Walden University's 
mission of positive social change and the HP2030 goals. 
Recommendations 
 Based on the review and analysis of literature, evidence, and expert opinion, the 
DNP student developed a CPG with recommendations and a practice protocol, including 
staff roles and responsibilities. This can be viewed in Appendix F and G. The CPG is 
intended to optimize patient care and address the gap in practice related to the lack of a 
standardized process for CRC screening interventions. The CPG incorporates strategies 
to provide nursing staff and providers with a well-defined protocol that promotes the 
consistent use of evidence-based strategies to improve CRC screening rates in the 
practice. The key evidence that supports the recommendations and protocol are 
summarized below:  
• CRC screening is a key national strategy for prevention and early detection of 
CRC (Shellnut, 2020). 
• Adhering to screening guidelines can avert more than 200,000 new cases and 
deaths in the next 20 years (Murphy et al., 2017). 
• The most recent update continues to recommend CRC screening in adults aged 50 
to 75 years and now recommends offering screening starting at 45 years for ALL 
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adults even if risk factors are absent. The decision to screen between age 76 and 
85 years is still based on individual patient screening history, patient preference, 
and overall health status. Screening should be discontinued after age 85. Those 
with increased risk or family history should be screened at an earlier age 
(USPSTF, 2021). 
• Screening options include stool-based testing: (a) high-sensitivity quiac-based 
fecal occult blood testing (HSgFOBT) or fecal immunochemical test (FIT) every 
year, and (b) stool DNA-FIT every 1 to 3 years; and direct visualization tests: (a) 
computed tomography (CT) colonography every 5 years, (b) flexible 
sigmoidoscopy every 5 years, flexible sigmoidoscopy every 10 years plus annual 
FIT, and colonoscopy every 10 years (USPSTF, 2021). 
• The two most common screening methods for average-risk patients is a 
colonoscopy every ten years or annual stool-based blood testing (NCCRT, 2020)  
• All screening options are acceptable, and the best option is the one that will get 
done (USPSTF, 2021). 
• Provider and patient communication are critical in selecting the screening 
modality that will get done (Volk et al., 2018). 
• Patients are more adherent to CRC screening when presented with options that 
meet their preferences and considers the population’s barriers to screening; The 
decision-making should be collaborative (Volk et al., 2018). 
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• Patients are less adherent to screening when colonoscopy alone is recommended 
than to when stool-based screening alone or a choice of both options 
(Triantafillidis et al., 2017). 
• There is no overwhelming evidence that one option is more effective than the 
other (Shellnutt, 2020).  
• The number one reason patients receive CRC screening is because their PCP 
recommended the screening; thus, provider engagement is critical (Paskett & 
Khuri, 2015; Triantafillidis et al., 2017). 
• Primary care team awareness about the importance of CRC and defining roles to 
implement multiple evidence-based interventions has shown to be an effective 
approach at improving CRC screening rates in primary care practice (Holden et 
al., 2020). 
• Several studies show that a team-based approach is effective at improving 
practice efficiencies such as preventive screening services (Jerzak, 2019). 
• One study showed an 11% increase in patients up to date for CRC screening with 
MA involvement in an expanded role (Jerzak, 2019; Miller, 2019). 
• Another study yielded a 123% increase in colonoscopy referrals when the MA 
role was expanded (Miller, 2019). 
• Multiple studies provide evidence for the critical role of primary care and the use 
of multilevel interventions (provider level, patient level, and practice/system 




• Multicomponent interventions increase CRC screening by any test by a median of 
15.4%when compared with no intervention (CPSTF, 2017). 
• Evidence-based interventions prioritized by the CDC as most helpful in increasing 
CRC screening rates, include: (a) patient reminders, (b) provider reminders, (c) 
provider assessment and feedback on performance, (d) reducing structural 
barriers, (e) patient navigation, and (f) small media such as videos and printed 
materials (CDC, 2020; Degroff et al., 2018).  
The evidence-based strategies reviewed from the literature and the P3 Model as 
the theoretical framework were both used to support and guide the development of the 
CPG. The following recommendations were formulated and categorized into three 
encounter levels (i.e., the practice, the provider, and the patient) for practice 
implementation: 
• Practice-Level recommendations include 
o Ensure all staff, including new hires, review and understand the CRC 
screening protocol and staff roles and responsibilities (See Appendix G). 
o Define and assign staff roles for CRC screening activities within the CRC 
screening protocol (See Appendix G). 
o Provide current education to all staff regarding the importance of CRC 
screening, the impact of disease outcomes, screening recommendations, 
and instructions for colonoscopy and FIT testing (See Appendix H). 
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o Ensure CRC screening educational material is available in each patient 
exam room (e.g., literature and video for patients) to be provided to 
patients due for CRC screening. 
o Utilize the electronic medical record (EMR) to support practice and 
system-level interventions (e.g., health maintenance records to identify 
patients due for screenings during pre-visit planning and intake, provider 
reminders, and updating patient records with screening dates and results). 
o Conduct morning huddles to provide provider/staff reminders. 
o Provide care coordination and referral services to assist patients with 
referral management, follow-up, closing the loop, and removing barriers 
(i.e., transportation, referral assistance, and prior authorization). 
o Monitor and track performance to provide feedback to staff on practice 
performance for CRC screening rate. 
o Post CRC screening posters in the exam room and waiting area. 
• Provider-Level recommendations include 
o Provide providers with educational material related to changes in 
screening recommendations (See Appendix H). 
o Provider to adopt standardized, evidence-based protocols for CRC 
screening.  
o Provider to assess EMR prompts, Health Maintenance, and/or MA/Nurse 
prompts for patients who need CRC screening. 
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o The provider communicates with the patient/family about risk factors and 
screening options (e.g., FIT testing annually or colonoscopy every 10 
years), making appropriate recommendations using standard patient 
decision-making tools if needed (Appendix H).  
o The provider supports patient decisions and encourages compliance 
o Provider to initiate referral and communicate with MA/Nurse/Referral 
Coordinator for follow up 
o Provider explains next steps to the patient (e.g., consult with GI specialist 
before scheduling colonoscopy and bowel prep for colonoscopy). 
o Provider to assess for potential barriers and communicate to care team for 
care coordination and navigation services. 
o Provider to set reminders within EMR for follow-up with the patient. 
o Provider letters to be sent to patients due for a screening or who have not 
returned the FIT test. Sample letters can be viewed in Appendix I. 
• Patient-Level recommendations include 
o Patient educational material is provided to patients due for CRC screening, 
including a video link for CRC and screening options while in the office if 
possible or mailed to home (See Appendix H) 
o Patient reminders are sent via phone call, text, or letter to patients 
identified as due for CRC screening or needing returned FIT test. Sample 
letters can be viewed in Appendix I. 
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o Follow up with patients who were given a colonoscopy referral or FIT test 
kit and have not returned the kit or completed the colonoscopy after one 
month. If not returned or completed, continue to follow up every month 
for up to 3 months after the initial kit or referral is given with a phone call, 
text, or letter. A phone call or personal contact is preferred. 
o Patient reminder calls are made for patient appointments. 
o Patient outreach and navigation services are provided as needed to assist 
with barriers such as transportation, bowel prep, and insurance 
authorization. 
Contribution of the Doctoral Project Team 
The project team was engaged in the initial discussions related to the practice 
performance and gaps in practice with CRC screening. Initially, the project team 
consisted of the practice manager, two practice providers, including one family nurse 
practitioner and one physician, the director of quality, the Chief Medical Officer (CMO), 
and the DNP student. The nurse manager and two additional practice providers (a family 
practice physician and a physician's assistant) joined the team during the review and 
appraisal of the CPG. In addition, the Director of Quality was replaced by the Director of 
Nursing Education during the review and appraisal of the CPG due to competing 
priorities related to an upcoming Joint Commission survey. All project team members 
were aware of the practice problem and made significant contributions to the 
development of the CPG. There was a consensus amongst the team that effective CRC 
screening strategies, including a standard workflow for support staff, were needed to 
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implement best practices in the practice for CRC screening activities. One project team 
member shared a study that contributed to the evidence. The project team was presented 
with information about the practice problem and performance, local and national targets, 
and evidence to support the DNP project. Once the DNP student developed the CPG, the 
project team reviewed and appraised the contents of the CPG for quality and validity 
using the AGREE II tool. The project team was engaged and provided comments and 
recommendations to help revise and finalize the CPG prior to implementation.  
For future plans outside the scope of this DNP project, the project team will 
submit the finalized CPG to the medical executive council (MEC) for organizational 
approval and systemwide adoption. Additionally, the team is interested in assessing CRC 
screening rates pre and post guideline and protocol implementation for future plans 
outside the scope of this DNP project. 
Strengths and Limitations of the Project 
This DNP project provides the practice site with effective strategies and a 
standard protocol to guide CRC screening interventions. The project's strengths include 
ample current literature to support evidence-based strategies to improve CRC screening 
interventions in the practice. Other strengths include having an expert panel that is very 
knowledgeable and supportive of the process for translating evidence-based 
recommendations into practice; and having a relevant topic to local and national public 
health goals. Additionally, the expanded role of the MA in the practice provided a unique 
resource opportunity for the implementation of this project; however, it can be a 
limitation for other practices.  
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The DNP project also had limitations. The CPG and practice protocol was 
developed based on a specific staffing model that requires involvement from several team 
members including MAs, and referral coordinators, to support the strategies. Other 
practices may not have the same staffing model and are therefore unable to implement. 
Lastly, there is no standard process described for auditing staff compliance with the CPG 
and practice protocol. The practice will need to rely on assessing practice and provider 
CRC screening rates to evaluate success. 
Recommendations for future projects of similar nature would be to consider 
alternative staffing models when developing the guideline and practice protocol and 
provide practical suggestions. Additionally, consider ways to audit staff compliance with 
the CPG and protocol to evaluate utilization and ultimately success.  
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Section 5: Dissemination Plan 
Once the expert panel approved the CPG and agreed that the guideline and 
practice protocol was appropriate for implementation, a meeting was scheduled with the 
practice leadership to discuss the plan for dissemination and implementation. During the 
meeting, it was decided to present the CPG and protocol and the educational resources to 
support the initiative to all staff during the next department meeting. All staff will be 
required to sign documentation that they received a copy of the CPG and practice 
protocol and understand the staff's roles and responsibilities. The documentation will be 
included in each employee's competency file. New hires will be required to review the 
CPG and sign off that they reviewed and understand as part of their orientation. An 
implementation date for the CPG and protocol was established and sent to all staff via the 
outlook calendar. The practice leadership will ensure that all staff is compliant with 
reviewing the CPG. After implementation, leadership will ensure the protocol is followed 
by performing practice rounds, chart reviews, and communicating with providers and 
staff about how things are going. 
Other primary care practices within the health system face similar challenges with 
CRC screening rates as the practice site for this DNP project. Outside the scope of this 
DNP project, the DNP scholar intends to work with the practice site's CMO and Director 
of Quality to obtain system approval for the CPG. The CPG will be presented to the MEC 
for board approval, then submitted to the system's Quality Committee for approval as a 
systemwide CPG. The guideline will then be uploaded to the organization's ambulatory 
policy library, which will be made available to other practices. Additionally, the DNP 
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scholar intends to collaborate with the system's Director of Ambulatory Services and 
Chief Nursing Officer to develop a plan for communicating and disseminating the 
guideline to other practices as a practice protocol. Also, as a member of the American 
Academy of Ambulatory Care Nursing (AAACN), the DNP scholar finds it appropriate 
to share the CPG and practice protocol on the AAACN's Open Forum for all special 
interest groups and communities to have access to for dissemination.  
Analysis of Self 
The completion of this DNP project provided an opportunity for me to enhance 
and develop skills as an advance practice clinician (APC), scholar, and project manager. 
As an APC and nurse leader, this DNP project and learning experience aligned with my 
organization's quality improvement goals and personal leadership goals. It afforded me 
the opportunity to utilize advanced competencies to evaluate practice interventions and 
engage in scholarly dissemination of EBP activities that promote improved health 
outcomes such as CRC screening. As a nurse leader, this DNP project gave me better 
insight into the importance of utilizing evidence and theoretical frameworks to 
collaborate and lead the practice improvement initiative. It expanded my scholarly 
language and gave me the confidence to effectively communicate and influence 
evidence-based practice changes amongst senior leadership and physician leaders. The 
project also positioned me for future growth in the organization as a scholar-practitioner. 
Through the scholarship of application, I was able to apply knowledge about 
evidence-based CRC screening interventions to solve a problem or address a gap in 
practice. According to the AACN's 2011 DNP Essentials, this application entails the 
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translation of research into practice and the dissemination and integration of new 
knowledge, both of which are critical activities for DNP graduates. This DNP project also 
involved the application of relevant findings to develop a practice guideline and improve 
clinical practice and the practice environment. Dissemination is an important aspect of 
clinical scholarship. Becoming comfortable and proficient in disseminating knowledge to 
be translated into practice are the characteristics of a scholar-practitioner and nurse leader 
that I believe I have become through this DNP project experience. 
 As a nurse leader in a resource-constrained organization, I was involved in several 
major initiatives throughout this DNP project experience. It was extremely challenging at 
times, but I recognized that managing multiple projects and responsibilities, including the 
DNP project, was critical for me as a leader and DNP scholar. This DNP journey required 
project management skills and tools to assist me in engaging key stakeholders for my 
DNP project, meeting deadlines, and prioritizing multiple tasks related to the DNP 
project and other projects. I was able to further develop project management skills 
through collaboration with other leaders and the use of project management tools. I 
intend to continue honing this skill by utilizing project management and prioritization 
tools to assist me in concurrently managing multiple initiatives and meeting 
organizational and personal goals. 
 There were several challenges experienced while completing this DNP project. As 
previously stated, there were multiple major initiatives taking place at one time. The 
practice site was going through a major transition due to being acquired by another health 
system. The transition to the new health system significantly impacted practice changes 
51 
 
related to a new information system, new policies, and resource changes. The transition 
also created issues with stakeholder engagement due to increased workload and changes 
in roles.  
 It became increasingly difficult to manage my workload and maintain a focus on 
meeting my DNP project deadlines. I was forced to prioritize and alter project deadlines 
to accommodate the transition and ensure adequate resource allocation and stakeholder 
engagement. Not to mention that I was actively involved in the organization's COVID 19 
pandemic management activities. I personally lost two close relatives to COVID 19 and 
my 44-year-old sister-in-law to colon cancer during this time. The loss of my sister-in-
law became a motivator for me to complete this project and establish best practices for a 
CPG and practice protocol that would assist providers and staff in implementing 
evidence-based strategies for CRC screening activities and ultimately improve health 
outcomes associated with CRC. The insight gained during my DNP journey to overcome 
numerous obstacles reinforced the critical role of frameworks in guiding evidence 
appraisals, effective goal setting, prioritization, communication, and collaboration. 
Additionally, project management skills and tools aided me in completing this DNP 
project. 
Summary 
 CRC remains a significant public health problem in the United States, but it does 
not have to be. CRC screening has the potential to save numerous lives. Although 
primary care practices are uniquely positioned to increase CRC screening uptake, 
screening rates continue to be low. Having a CPG with a practice protocol can assist 
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practices in the primary care setting in making positive changes. This DNP project 
contributes knowledge to a CPG that will help transform practices and establish a 
standard of care for CRC screening interventions. It has been demonstrated that 
implementing a CPG with evidence-based strategies for primary care providers and staff 
will improve CRC screening activities in the primary care practice setting. It is critical for 
the doctorate-prepared nurse scholar to disseminate knowledge to improve patient care 
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Appendix B: OCEBM Levels of Evidence 2011 
 
Note: Adapted from “Oxford 2011 Levels of Evidence” by OCEBM Levels of Evidence Working Group 
(http://www.cebm.net/index.aspx?o=5653)  
Question Step 1 (Level 1) Step 2 (Level 2) Step 3 (Level 3) Step 4 (Level 4) Step 5 (Level 5)
How common is the problem?
Local and current random 
sample surveys (or censuses)
Systematic review of surveys that 
allow matching to local 
circumstances Local non-random sample Case-series n/a
Is this diagnostic or monitoring test 
accurate? (Diagnosis)
Systematic review of cross 
sectional studies with 
consistently applied reference 
standard and blinding
Individual cross sectional studies 
with consistently applied 
reference standard and blinding
Non-consecutive studies, or studies 
without consistently applied 
reference standards
Case-control studies, or poor or 
non-independent reference 
standard Mechanism-based reasoning
What will happen if we do not add 
a therapy? (Prognosis)
Systematic review of inception 
cohort studies Inception cohort studies
Cohort study or control arm of 
randomized trial
Case-series, case-control studies, or 
poor quality pronostic cohort 
study n/a
Does this intervention help? 
(Treatment Benefits)
Systematic review of 
randomized trials or n-of-1 
trials
Randomized trial or 




Case-series, case-control studies, or 
historically controlled studies Mechanism-based reasoning
What are the COMMON harms? 
(Treatment Harms)
Systematic review of 
randomized trials, nested case-
control studies, n-of-1 trial 
with the patient you are raising 
the question about, or 
observational study with 
dramatic effect
Individual randomized trial or 
(exceptionally) observational 
study with dramatic effect
What are the RARE harms? 
(Treatment Harms)
Systematic review of 
randomized trials or n-of-1 trial 
Randomized trial or 
(exceptionally) observational 
study with dramatic effect
Is this (early detection) test 
worthwhile? (Screening)
Systematic review of 
randomized trials Randomized trial  
Non-randomized controlled 
cohort/follow-up study
Case-series, case-control studies, or 
historically controlled studies Mechanism-based reasoning
Non-randomized controlled 
cohort/follow-up study (post-
marketing surveillance) provided 
there are sufficient numbers to rule 
out a common harm. (For long-term 
harms the duration of follow up 
must be suffient)
Case-series, case-control studies, or 
historically controlled studies Mechanism-based reasoning
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Note. Reprinted from “JHNEBP Evidence Level and Quality Guide” by John Hopkins Medicine Center for EBP 
(https://www.hopkinsmedicine.org/evidence-based-practice/ijhn_2017_ebp.html). Copyright 2017 by The Johns Hopkins 
Hospital/Johns Hopkins University School of Nursing. Reprinted with permission. 
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Appendix D: Permission Notice for JHNEBP Model 
JOHNS HOPKINS EBP MODEL AND 
TOOLS- PERMISSION  
  
Thank you for your submission. We are happy to give you permission to use the Johns Hopkins Evidence-Based 
Practice model and tools in adherence of our legal terms noted below:  
  
• You may not modify the model or the tools without written approval from Johns Hopkins.   
• All reference to source forms should include “©The Johns Hopkins Hospital/The Johns Hopkins University.”  
• The tools may not be used for commercial purposes without special permission.    
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Author/Date Source Design Topic Strategy Findings Implications Limitations Level of 
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Appendix F: Clinical Practice Guideline for Colorectal Cancer (CRC) Screening in Ambulatory 
Practices 
MICHELLE BERKLEY-BROWN, DOCTORAL CANDIDATE 
 
REPORT DATE: AUGUST 1, 2021 
 
QUESTION  
In a primary care practice, in which CRC screening rates are low amongst adults 50 to 75 years 
of age, what best practices contribute to a CPG for CRC screening in the primary care setting? 
 
TARGET POPULATION  
Asymptomatic adults 45 years or older who are average risk for CRC, for example no prior 
diagnosis of CRC, adenomatous polyps, or inflammatory bowel disease 
 
RESPONSIBILITIES/ STAKEHOLDERS 
MD/DO, NP/PA, RN, LPN, MA, All Practice team members 
 
PURPOSE  
• To increase healthcare professionals’ adherence to evidence-based best practices and 
national recommendations for CRC screening activities.  
• To ensure that ambulatory clinics and outpatient settings will implement a comprehensive 
CRC screening process  
• To provide a framework (Practice-, Provider-, and Patient-P3 Model) that will help guide 
interventions that improve CRC screening activities and result in more effective and 
long-lasting outcomes.   
SCOPE  
Ambulatory and outpatient clinic areas  
 
FRAMEWORK AND REFERENCE 
Evidence was carefully reviewed, appraised, and synthesized from 13 recent (within the past 5 
years) studies including systematic reviews and peer-reviewed articles, and guidelines from 
government and professional organizations to develop this protocol. Recommendations from the 
USPSTF were utilized because they are based on a rigorous review of existing peer-reviewed 
evidence and are intended to help primary care clinicians make decisions regarding preventive 
services and patient's needs. In addition, the CDC’s Guide to Community Preventive Services 
(CDC, 2020), and the ACS's National Colorectal Cancer Roundtable's (NCCRT) manual: Steps 
for Increasing Colorectal Cancer Screening Rates: A Manual For Community Health Centers 
(NCCRT, 2020) were chosen because they were most appropriate to the target population. Also, 
The P3 Model is used as a framework to guide the interventions. It focuses on all three levels of 
the clinical encounter – the practice, provider, and patient. Practical interventions are designed 
for each level while considering the impacting factors at each level (e.g., organizational, 
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• CRC is the second leading cause of cancer deaths in the United States (US) for both men 
and women combined 
• Evidence reports that CRC screening is an effective way to reduce mortality and 
morbidity related to CRC 
• CRC screening is a pivotal national strategy for prevention and early detection of CRC; It 
can prevent and allow for early detection when treatment and recovery are most effective 
(Shellnut, 2020). 
• Evidence shows that adhering to screening guidelines can avert more than 200,000 new 
cases and deaths in the next 20 years (Murphy et al., 2017).  
• Age is one of the most important risk factors for CRC, with incidence rates increasing 
with age and nearly 94% of new cases of CRC occurring in adults 45 years or older 
• The most recent update by the U.S. Preventive Services Task Force (USPSTF,2021) 
continues to recommend CRC screening in adults aged 50 to 75 years, and now 
recommends offering screening starting at 45 years for ALL adults even if risk factors are 
absent. The decision to screen between age 76 and 85 years is still based on individual 
patient screening history, patient preference, and overall health status. Screening should 
be discontinued after age 85. 
• Those with increased risk or family history should be screened at an earlier age. 
• USPSTF recommended screening options include stool-based testing: (a) high-sensitivity 
quiac-based fecal occult blood testing (HSgFOBT) or fecal immunochemical test (FIT) 
every year, and (b) stool DNA-FIT every 1 to 3 years; and direct visualization tests: (a) 
computed tomography (CT) colonography every 5 years, (b) flexible sigmoidoscopy 
every 5 years, flexible sigmoidoscopy every 10 years plus annual FIT, and colonoscopy 
every 10 years. 
• The two most common screening methods for average-risk patients is a colonoscopy 
every ten years or annual stool-based blood testing (NCCRT, 2020)  
• The USPSTF (2021) emphasizes that all options are acceptable and that the focus should 
be on getting the screening completed since there is strong evidence that screening 
reduces the incidence and mortality of CRC; the best option is the one that will get done. 
• Provider and patient communication is critical in selecting the screening modality that 
will get done 
• Research shows that patients are more adherent to CRC screening when presented with 
options that meet their preferences; The decision-making should be collaborative. 
• Patients are less adherent to screening when colonoscopy alone is recommended than to 
when stool-based screening alone or a choice of both options (Triantafillidis et al., 2017). 
• There is no overwhelming evidence that one option is more effective than the other 
(Shellnutt, 2020).  
• The primary care provider (PCP) can play an essential role in encouraging people to be 
screened; Studies show the number one reason patients receive CRC screening is because 
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their PCP recommended the screening thus provider engagement is critical critical 
(Triantafillidis et al., 2017; Paskett and Khuri, 2015). 
• Primary care team awareness about the importance of CRC and defining roles to 
implement multiple evidence-based interventions has shown to be an effective approach 
at improving CRC screening rates in primary care practice (Holden et al., 2020). 
• Several studies support the role of the primary care team in adherence to CRC screening 
strategies; Awareness about the importance of CRC to the team and defining roles to 
implement multiple evidence-based interventions has shown to be an effective approach 
at improving CRC screening rates in primary care practice (Jerzak, 2019). 
• One study showed an 11% increase in patients up to date for CRC screening with MA 
involvement in an expanded role (Jerzak, 2019; Miller, 2019). 
• Another study yielded a 123% increase in colonoscopy referrals when the MA role was 
expanded (Miller, 2019). 
• Multicomponent interventions increase CRC screening by any test by a median of 15.4% 
when compared with no intervention (CPSTF, 2017). 
• Multiple studies provide evidence for the critical role of primary care and the use of 
multilevel interventions (provider level, patient level, and practice/system level) to 
increase rates of colorectal cancer screening and follow-up care (Kim et al., 2020; 
CPSTF, 2017). 
• Evidence-based interventions prioritized by the Centers for Disease Control and 
Prevention (CDC, 2020; Degroff et al., 2018) as most helpful in increasing CRC 
screening rates, include: (a) patient reminders, (b) provider reminders, (c) provider 
assessment and feedback on performance, (d) reducing structural barriers, (e) patient 
navigation, and (f) small media (videos and printed materials).  
RECOMMENDATIONS 
All recommendations were derived from consistent level 1 to 3 sources of evidence that was 
evaluated for quality, value, and relevance using the CEBM and JHNEBP models to develop 
guidelines for CRC screening in the primary care setting. The strength of the recommendations 
were graded and based on the body of evidence ranging from A for high quality or consistent 
level 1 studies, B for good quality or consistent level 2 or 3 studies or extrapolations from level 1 
studies, C for low quality or level 4 studies, and D for level 5 or inconsistent studies. A summary 
of the evaluation can be found in Appendix E.  
 
Practice-Level 
• Ensure all staff, including new hires, review and understand the CRC screening protocol 
and staff roles and responsibilities 
• Define and assign staff roles for CRC screening activities within the CRC screening 
protocol 
• Provide current education to all staff regarding importance of CRC screening, impact of 
disease outcomes, screening recommendations. 
• Ensure CRC screening educational material is available in each patient exam room (ie. 
literature and video for patients) to be provided to patients due for CRC screening 
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• Utilize the electronic medical record (EMR) to support practice and system level 
interventions ie. health maintenance records to identify patients due for screenings during 
pre-visit planning and intake, provider reminders, and updating patient records with 
screening dates and results 
• Conduct morning huddles to provide provider/staff reminders 
• Provide care coordination and referral services to assist patients with referral 
management, follow-up, closing the loop, and removing barriers ie. transportation, 
referral assistance, and prior authorization 
• Monitor and track performance inorder to provide feedback to staff on practice 
performance for CRC screening rate 
• Post CRC screening posters in exam room and waiting area 
 
Provider-Level  
• Provide providers with educational material related to changes in screening 
recommendations  
• Provider to adopt standardized, evidence-based protocols for CRC screening.  
• Provider to assess EMR prompts, Health Maintenance, and/or MA/Nurse prompts for 
patients who are in need of CRC screening. 
• Provider communicates with patient/family about risk factors and screening options (FIT 
testing annually or colonoscopy every 10 years) making appropriate recommendation 
using standard patient decision making tool if needed  
• Provider supports patient decision and encourages compliance 
• Provider to initiate referral and communicate with MA/Nurse/Referral Coordinator for 
follow up 
• Provider explains next steps to patient ie. consult with GI specialist prior to scheduling 
colonoscopy and bowel prep for colonoscopy. 
• Provider to assess for potential barriers and communicate to care team for care 
coordination and navigation services. 
• Provider to set reminders within EMR for follow up with patient. 
• Provider letters sent to patients due for screening, or who have not returned FIT test 
 
Patient-Level  
• Patient educational material provided to patients due for CRC screening including a video 
link for CRC and screening options while in the office if possible or mailed to home  
• Patient reminders sent via phone call, text, or letter to patients identified as due for CRC 
screening or needing returned FIT test 
• Follow up with patients who were given colonoscopy referral or FIT test kit and have not 
returned the kit or completed the colonoscopy after one month, and continue to follow up 
if not returned or completed every month for up to 3 months after the initial kit or referral 
given with phone call, text, or letter. Phone call or personal contact preferred. 
• Patient reminder calls made for patient appointments 
• Patient outreach and navigation services provided as needed to assist with barriers such 




This guideline will be updated based on the organization policy of at least annually and no longer 
than every 3 years. All work produced in this guideline is free from bias due to competing interests. 
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Appendix G: Colorectal Cancer Screening Protocol with Staff Roles 
Medical Assistant/Nurse 
▪ Review health maintenance record during intake at every visit and during pre-visit 
planning to identify patients due for screening 
▪ Alert provider that patient is due for CRC screening 
▪ For patients due for CRC screening, provide CRC screening educational material, and 
video to view while waiting for provider or other appropriate time during the visit as 
needed (Refer to educational material at the end of this protocol in Appendix H). 
▪ Update record as needed with CRC screening dates and results 
▪ Collaborate with provider to provide after visit education and instructions regarding CRC 
screening recommendation, referral, and next steps 
▪ Communicate and collaborate with referral coordinator as needed for scheduling of GI 
consult and colonoscopy for the patient 
▪ Provide patient with FIT test and instructions for collection and return. (FIT test 
instructions can be viewed in the educational material located in Appendix H).). 
▪ Complete FIT test log to track patient completion, returns, and results 
▪ Provide patient reminders for FIT tests via phone call, text, or patient letters if not 
returned in 1 month. See sample letters in Appendix I. Continue to provide reminders 
monthly up to 3 months after initial kit given. Phone calls or in person reminders 
preferred after initial reminder. 
▪ Communicate and collaborate with GI specialist and MA/Nurse post-visit to schedule 
colonoscopy if ordered and provide patient with instructions as needed 
▪ Provide patient reminders for appointments via phone or text 




▪ Receive referrals from practice and schedule appointment with GI specialist for 
colonoscopy consult as needed 
▪ Follow up with patients per referral policy 
▪ Provide assistance with scheduling transportation as needed 
▪ Communicate and collaborate with GI specialist and MA/Nurse post-visit to schedule 
colonoscopy if ordered and provide patient with instructions as needed 
▪ Provide patient reminders for colonoscopies via phone call, text, or patient letters. See 
sample letters in Appendix I.  
▪ Follow up with patient if appointment missed to reschedule and identify reason for 
missed appointment. 
▪ Track and close loop of referrals by ensuring completion of the referral and obtaining the 
results for record to be sent to referring provider.  
▪ Collaborate and communicate with provider and care team to provide patient reminders, 
patient outreach and navigation services.  





▪ Review Health Maintenance record during visit with each patient to identify patient due 
for CRC screening 
▪ Educate patient/family on importance of CRC screening, discuss risk factors, and discuss 
recommended CRC screening options (i.e., annual FIT test, and colonoscopy every 10 
years). 
▪ Make appropriate recommendation using standard patient decision making tool if needed 
(contained in the educational material found in Appendix H). 
▪ Ensure shared decision making in which provider and patient share information and reach 
consensus about what screening test is best for the patient 
▪ Provide after visit instructions  
▪ Provide patient follow up for results 
▪ Collaborate with care team to provide patient reminders and patient outreach via phone or 
letters 
▪ Obtain updated screening recommendations (contained in the educational material 
located in Appendix H). 




▪ Ensure that all staff and new employees are oriented to guideline for CRC screening and 
trained for adequate EMR documentation. 
▪ Ensure that all staff has reviewed current education regarding importance of CRC 
screening, impact of disease, and screening recommendations. 
▪ Ensure guideline is being followed. 
▪ Provide provider assessments and feedback of performance on CRC screening rate. 
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Important Facts for African Americans about Colorectal Cancer 
 
• The rate of being diagnosed with colorectal cancer is higher among African Americans than 
among any other population group in the U.S. 
• Death rates from colorectal cancer are higher among African Americans than any other 
population group in the U.S. 
• Experts suggest that African Americans get screened beginning at 45 
• There is evidence that African Americans are less likely than Caucasians to get screened for 
colorectal cancer 
• African Americans are more likely to be diagnosed with colorectal cancer in advanced stages 
when there are fewer treatment options available. They are less likely to live 5 or more years after 
being diagnosed with colorectal cancer than other populations. 
• Diet, tobacco use and lack of access to equal medical treatment options may increase African 
Americans’ risk of developing colorectal cancer. 
• There may also be genetic factors that contribute to the higher incidence of colorectal cancer 
among some African Americans. Learn your family’s medical history and tell your primary care 
provider if a relative (parent, brother, sister or child) has had colorectal cancer or colorectal 
polyps. 
• African American women are more likely to die of colorectal cancer than are women of any other 
population group. 
• African American patients experience a larger number of polyps on the right side of the colon, 




American Society of Gastrointestinal Endoscopy. (n.d.). What African Americans Need to Know 













• Colonoscopy is an examination of the large intestines (colon)  
• It is used to screen for colorectal cancer and also used as a follow up test if 
anything unusual is found during one of the other screening tests like the FIT 
test  
• Before the test you need to pick up a prep prescribed by your doctor and 
start the day before  
• You will receive medication during the test to make you comfortable  
• The doctor will use a flexible lighted tube to check for polyps or cancer 
inside your rectum and entire colon  
• During the test the doctor can find and remove most polyps and some 
cancers  
• This test should be done every 10 years.  
• If polyps or cancers are found during the test, you will need more frequent 

















Colorectal Cancer (CRC) Quiz and Answer Key  
  
1. Who gets colorectal cancer?  
a)Men only b)women only c)both men and women  
 
The correct answer is:  
Both men and women  
Colorectal cancer affects men and women of all racial and ethnic groups.  
  
2. Colorectal cancer is the second leading cancer killer in the United States  
True or False  
  
The correct answer is:  
True  
Of cancers affecting both men and women, colorectal cancer is the second leading cancer 
killer in the United States and the third most common cancer in men and in women.  
3. Getting screened for colorectal cancer can help you prevent the disease.  
True or False  
  
The correct answer is:  
True  
Screening helps find precancerous polyps (abnormal growths) in the colon and rectum so 
they can be removed before they turn into cancer. Screening also helps find colorectal 
cancer early, when treatment works best.  
  
4. If you don’t have any symptoms, it means you don’t have colorectal cancer.  
True or False  
  
The correct answer is:  
False  
Colorectal polyps and colorectal cancer don’t always cause symptoms, especially early 
on. But screening can find polyps and colorectal cancer even before symptoms appear. 
That is why getting screened regularly for colorectal cancer is so important.  
  
5. Screening is recommended to begin at what age?  
a)40, b)50, c)60, d)70  
  
The correct answer is:  
50  
Your risk of getting colorectal cancer increases as you get older. About 90% of cases 
occur in people who are age 50 or older. However, you may need to be tested earlier or 
more often than other people if you have inflammatory bowel disease such as 
Crohn’s disease or ulcerative colitis, a personal or family history of colorectal cancer or 
colorectal polyps, or a genetic syndrome such as familial adenomatous polyposis (FAP) 
or hereditary non-polyposis colorectal cancer (Lynch syndrome). If you think any of 
these things is true for you, ask your doctor when and how often you should be 
tested. The American Cancer Society recommends lowering the age to 45 years.  
  
6. At what age can you stop getting screened for colorectal cancer?  
91 
 
a)60, b)65, c)70, d)75, e)80  
  
The correct answer is:  
75  
Regular screening is recommended for adults ages 50 to 75. If you are between 76 and 
85, ask your doctor if you should be screened.  
  
7. The only screening test for colorectal cancer is colonoscopy.  
True or False  
  
The correct answer is:  
False  
There are several types of screening tests for colorectal cancer, including some that you 
can do at home. Learn about all of the screening test options and talk to your doctor about 
which is right for you. The best test is the one you do!  
  
8. Which of these are symptoms of colorectal cancer?  
a)Blood in stool or bowel movement,  
b)Stomach pain, aches, or cramps that don’t go away  
c)Losing weight and you don’t know why  
d)All of these  
e)None of these  
  
The correct answer is:  
All of these  
If you have any of these symptoms, talk to your doctor. They may be caused by 
something other than cancer. The only way to know what is causing them is to see your 
doctor.  
9. Medicare and most insurance plans cover colorectal cancer screening.  
True or False  
  
The correct answer is: True  
Check with your plan to see what is covered. In addition, free or low-cost screenings may 
be available for you. Six states in CDC’s Colorectal Cancer Control Program provide 
colorectal cancer screening to low-income men and women aged 50 to 64 years who are 
underinsured or uninsured for screening, when resources are available, and there is no 

















*Colorectal cancer screening promotion for African Americans - video 1 - YouTube  
https://youtu.be/HeA7KgSQRtA (2:20)  
  
Chadwick Boseman's private struggle with colon cancer | 20/20 (facebook.com)  
https://www.facebook.com/ABC2020/videos/1209469029419693/ (5:48 – 3:23 to 5:30)  
  
*What happens during and after a colonoscopy? - 
YouTube  https://www.youtube.com/watch?v=mh90RPA-C10 (5:14)  
  
CDC: Tips From Former Smokers - Asaad M. and Leah M.: We’re a Team - YouTube  













































On your last visit to your healthcare provider, _______________________________, you were 
given a test to screen for colorectal cancer.  
 
At this time, we have not received your test back. 
 
Colorectal cancer is treated most successfully when found in the early stages. Simple tests like 
having a stool test every year can help find cancer early. 
 
Please return your completed test kit to us as soon as possible. 
 






Your healthcare provider 
 
2000 West Baltimore Street 



















A year ago, you did a test to check for colon cancer. Your test was normal.  
But, colon cancer can start any time. And when cancer is starting, you do not feel anything. To 
protect yourself from colon cancer, you need to do this test every year. It is time to do the test 
again. The test checked for hidden blood in your stool, which is a sign of colon cancer. Last time, 
you put some stool (poop) into a tube and you will do the same again this year. The test is easy, 
you can eat whatever food you want to eat before the test.  
 
We have sent you the test kit with this letter. Just follow the instructions. Mail it to the lab, or drop 
it off to us as soon as you have done the test. The test and the postage is free. 
  
This simple test could save you life. Do it and send it in right away! 
 






Your healthcare provider 
 
2000 West Baltimore Street 



















Our office has made a commitment to promote the health of its members, and to provide education 
regarding preventive health measures that you can take to maintain a healthy lifestyle. Our records 
indicate that you are either overdue for colorectal cancer screening tests, or that you have never 
had a colorectal cancer screening test.  
 
I am writing to ask you to call our office today to schedule a colorectal cancer screening 
appointment. By getting colorectal cancer screening tests regularly, colorectal cancer can be found 
and treated early when the chances for cure are best. Many of these tests can also help prevent the 
development of colorectal cancer.  
 
The American Cancer Society recommends that you have this screening at the age of 45.  
 
This test could save your life! 
 








2000 West Baltimore Street 
Baltimore, Maryland 21223 
410-362-3612 
 
 
 
 
 
 
 
